Related Image: Metal foam has a good memory |
...ch Professor Benjamin Cravatt, Ph.D., is being pub...Biological Chemistry. , The new study describes a ...d-for the biosynthesis of neurotransmitter lipids,...dogenous cannabinoid ("endocannabinoid") anandamid...(Abh4) in areas such as the central nervous system...
...righteningly large if only there was a greater con...udes. The study adds support to the theory that so...oic period because they had a much richer oxygen s...er. , The study, "No giants today: tracheal oxygen...presented Oct. 10 and 11 at Comparative Physiology...
...earch-and-destroy quest for weeds, will soon be mo... fields at the University of Illinois. What,s more...ile significantly reducing herbicide use. , The ro...ll cameras mounted on a frame on top of the machin...human, said Lei Tian, agricultural engineer at the...
Other Biology News:Nanotechnology propels advances in regenerative medicine research 2Giant insects might reign if only there was more oxygen in the air 2Giant insects might reign if only there was more oxygen in the air 3New system could drastically reduce herbicide use 2New system could drastically reduce herbicide use 3(Date:11/20/2009)...re/ -- Veridiam (www.veridiam.com) won the prestig...y at the 2009 Workplace Excellence Awards. The awa...an Resources Management and recognize innovative a...ridiam was one of nine winners, selected from more... the recent awards ceremony. San Diego-based Verid...
(Date:11/20/2009)...RNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NV...itten public offering of 6,800,000 shares of its c...share. The approximately $21 million of net proce...d commissions, will be used for preclinical studie...nternal research and development programs, working...
(Date:11/20/2009)...wire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (...th Circuit Court of Appeals reversed a U.S. Distri...d to pursue all of its claims against The Lash Gro...r trial. CTI filed a complaint against The Lash G...ltant for CTI,s product TRISENOX, in 2007 seeking ...
(Date:11/20/2009)...O recently announced that Dr. Dominique Hebrault w...cess Analytical Technology (PAT) in Green Chemistr.... , (PRWEB) November 20, ... Technology (PAT) in Green Chemistry and Green Eng...l Technology (PAT) case studies will be presented ...
Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Novavax Prices Public Offering of Common Stock 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2...yne, Inc.,(Nasdaq: RDYN ) announced today that it...2008 at 4:45 P.M. ET to report first quarter 2008,... Replidyne will host its,annual shareholder meetin...n Louisville, CO., Earnings conference call in...resident and CEO, and other members of Replidyne,s...
...Points from the First Quarter of 2007 to ...to Launch Newest Generation of Laser Lipolysis ...Mass., April 29 Cynosure, Inc.,(Nasdaq: CYNO ), ...ray of,light-based aesthetic treatment systems, to... the quarter ended March 31, 2008., First-Quarter...
...merica,Inc. (OTC Bulletin Board: CBAI), the umbili...tp://www.cordblood-america.com ) focused on,bring...ilies nationwide and,internationally, today report...erview with Francis Gaskins, said 2007 acquisition...d a 600 percent increase in gross profits., "We w...
Other Biology Technology:Replidyne to Report First Quarter 2008 Earnings 2Replidyne to Report First Quarter 2008 Earnings 3Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 2Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 3Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 4Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 5Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 6Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 7Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 8Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 9Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 10Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 11Cord Blood America CEO Matthew Schissler Says Operations Significantly Streamlined 2Streptavidin, PE conjugated/tagged from Invitrogen
Supercoiled DNA Ladder from Invitrogen
GIBCO RPMI Medium 1640; powder from Invitrogen
Rabbit Anti-Human Parathyroid Hormone Receptor 2 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: